Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males

[1] Chan WK(2013)Epidemiology of a fast emerging disease in the Asia-Pacific region—non-alcoholic fatty liver disease Hepatol Int 7 65-71

[2] Goh KL(2012)Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia Hepatol Int 7 548-554

[3] Goh SC(2013)Non-alcoholic fatty liver disease (NAFLD) in diabetics—prevalence and predictive factors in a multi-racial hospital clinic population in Malaysia J Gastroenterol Hepatol 28 1375-1383

[4] Ho ELM(2011)Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country J Gastroenterol Hepatol 26 1333-1337

[5] Goh KL(2012)The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 1592-1609

[6] Chan WK(2007)Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association Circulation 116 1081-1093

[7] Tan ATB(2003)The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers Journal of occupational health 45 335-343

[8] Vethakkan SR(2005)The metabolic syndrome—a new worldwide definition Lancet 366 1059-1062

[9] Tah PC(2009)Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 1640-1645

[10] Anushya V(1985)Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-419

[1] Chan WK(2013)Epidemiology of a fast emerging disease in the Asia-Pacific region—non-alcoholic fatty liver disease Hepatol Int 7 65-71

[2] Goh KL(2012)Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia Hepatol Int 7 548-554

[3] Goh SC(2013)Non-alcoholic fatty liver disease (NAFLD) in diabetics—prevalence and predictive factors in a multi-racial hospital clinic population in Malaysia J Gastroenterol Hepatol 28 1375-1383

[4] Ho ELM(2011)Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country J Gastroenterol Hepatol 26 1333-1337

[5] Goh KL(2012)The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 1592-1609

[6] Chan WK(2007)Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association Circulation 116 1081-1093

[7] Tan ATB(2003)The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers Journal of occupational health 45 335-343

[8] Vethakkan SR(2005)The metabolic syndrome—a new worldwide definition Lancet 366 1059-1062

[9] Tah PC(2009)Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation 120 1640-1645

[10] Anushya V(1985)Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412-419